Tepper SJ, Dong Y, Vincent M, Wietecha LA, et al. Sustained response of galcanezumab in migraine prevention: Patient-level data from a post hoc analysis in patients with episodic or chronic migraine. Headache 2023 May 3. doi: 10.1111/head.14494.
PMID: 37132481